BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37283515)

  • 1. Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer.
    Wu J; Liang J; Liu R; Lv T; Fu K; Jiang L; Ma W; Pan Y; Tan Z; Liu Q; Qiu W; Ge M; Wang J
    Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37283515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis.
    Liang J; Jin Z; Kuang J; Feng H; Zhao Q; Yang Z; Zhan L; Shen B; Yan J; Cai W; Cheng X; Qiu W
    Br J Cancer; 2021 Aug; 125(3):390-401. PubMed ID: 34088989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of anlotinib in thyroid cancer.
    Ruan X; Shi X; Dong Q; Yu Y; Hou X; Song X; Wei X; Chen L; Gao M
    Endocr Relat Cancer; 2019 Jan; 26(1):153-164. PubMed ID: 30139768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor Activity of Berberine by Activating Autophagy and Apoptosis in CAL-62 and BHT-101 Anaplastic Thyroid Carcinoma Cell Lines.
    Shi XZ; Zhao S; Wang Y; Wang MY; Su SW; Wu YZ; Xiong C
    Drug Des Devel Ther; 2023; 17():1889-1906. PubMed ID: 37397788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway.
    Hu Y; Wen Q; Cai Y; Liu Y; Ma W; Li Q; Song F; Guo Y; Zhu L; Ge J; Zeng Q; Wang J; Yin C; Zheng G; Ge M
    Phytomedicine; 2023 Jan; 108():154528. PubMed ID: 36343549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells.
    Liang L; Hui K; Hu C; Wen Y; Yang S; Zhu P; Wang L; Xia Y; Qiao Y; Sun W; Fei J; Chen T; Zhao F; Yang B; Jiang X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):71. PubMed ID: 30755242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsaicin inhibits the stemness of anaplastic thyroid carcinoma cells by triggering autophagy-lysosome mediated OCT4A degradation.
    Wu L; Xu S; Cheng X; Zhang L; Wang Y; Wu J; Bao J; Yu H; Lu R
    Phytother Res; 2022 Feb; 36(2):938-950. PubMed ID: 35076979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergic Induction of Autophagic Cell Death in Anaplastic Thyroid Carcinoma.
    Wächter S; Knauff F; Roth S; Keber C; Holzer K; Manoharan J; Maurer E; Bartsch DK; Di Fazio P
    Cancer Invest; 2023 Apr; 41(4):405-421. PubMed ID: 36811581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAFV600E/Mt to Vemurafenib.
    Jiao X; Zhang H; Xu X; Yu Y; Zhang H; Zhang J; Ning L; Hao F; Liu X; Niu M; Chen CT; Chen D; Zhang K
    Cell Physiol Biochem; 2018; 49(3):1143-1162. PubMed ID: 30196299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer.
    Jin Z; Cheng X; Feng H; Kuang J; Yang W; Peng C; Shen B; Qiu W
    Cell Physiol Biochem; 2017; 44(4):1471-1484. PubMed ID: 29190616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin C induces ferroptosis in anaplastic thyroid cancer cells by ferritinophagy activation.
    Wang X; Xu S; Zhang L; Cheng X; Yu H; Bao J; Lu R
    Biochem Biophys Res Commun; 2021 Apr; 551():46-53. PubMed ID: 33714759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibuprofen inhibits anaplastic thyroid cells in vivo and in vitro by triggering NLRP3-ASC-GSDMD-dependent pyroptosis.
    Guo H; Ma R; Zhang Y; Yin K; Du G; Yin F; Li H; Wang Z; Yin D
    Inflammopharmacology; 2024 Feb; 32(1):733-745. PubMed ID: 37999895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLK4 inhibitor exhibits antitumor effect and synergizes sorafenib via arresting cell cycle and inactivating Wnt/β-catenin pathway in anaplastic thyroid cancer.
    Zhu W; Xie B
    Cancer Biol Ther; 2023 Dec; 24(1):2223383. PubMed ID: 37351847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma.
    Wang Z; Qiu X; Zhang H; Li W
    J Biochem Mol Toxicol; 2020 May; 34(5):e22469. PubMed ID: 32173973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance.
    D'Aprile S; Denaro S; Pavone AM; Giallongo S; Giallongo C; Distefano A; Salvatorelli L; Torrisi F; Giuffrida R; Forte S; Tibullo D; Li Volti G; Magro G; Vicario N; Parenti R
    J Transl Med; 2023 Nov; 21(1):780. PubMed ID: 37924062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic inhibition of polo-like kinases in anaplastic thyroid cancer.
    Lin SF; Yeh CN; Huang YT; Chou TC; Wong RJ
    Cancer Sci; 2021 Feb; 112(2):803-814. PubMed ID: 33306266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.
    Saini S; Sripada L; Tulla K; Kumar P; Yue F; Kunda N; Maker AV; Prabhakar BS
    Cell Death Dis; 2019 Feb; 10(2):145. PubMed ID: 30760700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
    Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
    Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis.
    Zhang H; Yu Y; Zhang K; Liu X; Dai Y; Jiao X
    Bioengineered; 2019 Dec; 10(1):306-315. PubMed ID: 31299871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
    Hao F; Zhu Q; Lu L; Sun S; Huang Y; Zhang J; Liu Z; Miao Y; Jiao X; Chen D
    Oncol Res; 2020 Sep; 28(4):345-355. PubMed ID: 32138807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.